BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36121799)

  • 1. Detection of Cancer Marker Flap Endonuclease 1 Using One-Pot Transcription-Powered Clustered Regularly Interspaced Short Palindromic Repeat/Cas12a Signal Expansion.
    Ding S; Wei Y; Chen G; Du F; Cui X; Huang X; Yuan Y; Dong J; Tang Z
    Anal Chem; 2022 Oct; 94(39):13549-13555. PubMed ID: 36121799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controllable crRNA Self-Transcription Aided Dual-Amplified CRISPR-Cas12a Strategy for Highly Sensitive Biosensing of FEN1 Activity.
    Song Y; Gao K; Cai X; Cheng W; Ding S; Zhang D; Deng S
    ACS Synth Biol; 2022 Nov; 11(11):3847-3854. PubMed ID: 36240131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ultrasensitive biosensing platform for FEN1 activity detection based on target-induced primer extension to trigger the collateral cleavage of CRISPR/Cas12a.
    Cai X; Zhao D; Li X; Zheng Q; Shu X; Ding S; Zhang D; Yan Y
    Anal Chim Acta; 2022 Nov; 1233():340519. PubMed ID: 36283790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmable CRISPR-Cas12a and self-recruiting crRNA assisted dual biosensing platform for simultaneous detection of lung cancer biomarkers hOGG1 and FEN1.
    Cheng X; Xia X; Ren D; Chen Q; Xu G; Wei F; Yang J; Wang L; Hu Q; Zou J; Cen Y
    Anal Chim Acta; 2023 Feb; 1240():340748. PubMed ID: 36641157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal detection of flap endonuclease 1 activity through CRISPR/Cas12a trans-cleavage of single-strand DNA oligonucleotides.
    Cui C; Lau CH; Chu LT; Kwong HK; Tin C; Chen TH
    Biosens Bioelectron; 2023 Jan; 220():114859. PubMed ID: 36368142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target-activated T7 transcription circuit-mediated multiple cycling signal amplification for monitoring of flap endonuclease 1 activity in cancer cells.
    Zhang JZ; Zhao NN; Wang ZY; Hu J; Zhang CY
    Analyst; 2023 Jun; 148(12):2732-2738. PubMed ID: 37232199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A one-pot transcriptional assay method that detects the tumor biomarker FEN1 based on its flap cleavage activity.
    Song DY; Park YJ; Kim DM
    Anal Chim Acta; 2023 Nov; 1282():341928. PubMed ID: 37923413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Isothermal Method for Sensitive Detection of Mycobacterium tuberculosis Complex Using Clustered Regularly Interspaced Short Palindromic Repeats/Cas12a Cis and Trans Cleavage.
    Xu H; Zhang X; Cai Z; Dong X; Chen G; Li Z; Qiu L; He L; Liang B; Liu X; Liu J
    J Mol Diagn; 2020 Aug; 22(8):1020-1029. PubMed ID: 32470556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Cas12a-Based Cell-Free Small-Molecule Biosensors via Allosteric Regulation of CRISPR Array Expression.
    Mahas A; Wang Q; Marsic T; Mahfouz MM
    Anal Chem; 2022 Mar; 94(11):4617-4626. PubMed ID: 35266687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamer assisted CRISPR-Cas12a strategy for small molecule diagnostics.
    Niu C; Wang C; Li F; Zheng X; Xing X; Zhang C
    Biosens Bioelectron; 2021 Jul; 183():113196. PubMed ID: 33839534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Basis for Guide RNA Processing and Seed-Dependent DNA Targeting by CRISPR-Cas12a.
    Swarts DC; van der Oost J; Jinek M
    Mol Cell; 2017 Apr; 66(2):221-233.e4. PubMed ID: 28431230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets.
    Mengwasser KE; Adeyemi RO; Leng Y; Choi MY; Clairmont C; D'Andrea AD; Elledge SJ
    Mol Cell; 2019 Mar; 73(5):885-899.e6. PubMed ID: 30686591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the trans-cleavage activity of CRISPR-Cas12a for the development of a Mxene based electrochemiluminescence biosensor for the detection of Siglec-5.
    Zhang K; Fan Z; Yao B; Ding Y; Zhao J; Xie M; Pan J
    Biosens Bioelectron; 2021 Apr; 178():113019. PubMed ID: 33517231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas12a has both cis- and trans-cleavage activities on single-stranded DNA.
    Li SY; Cheng QX; Liu JK; Nie XQ; Zhao GP; Wang J
    Cell Res; 2018 Apr; 28(4):491-493. PubMed ID: 29531313
    [No Abstract]   [Full Text] [Related]  

  • 15. Editor's cut: DNA cleavage by CRISPR RNA-guided nucleases Cas9 and Cas12a.
    Swartjes T; Staals RHJ; van der Oost J
    Biochem Soc Trans; 2020 Feb; 48(1):207-219. PubMed ID: 31872209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Light-Start CRISPR-Cas12a Reaction with Caged crRNA Enables Rapid and Sensitive Nucleic Acid Detection.
    Hu M; Liu R; Qiu Z; Cao F; Tian T; Lu Y; Jiang Y; Zhou X
    Angew Chem Int Ed Engl; 2023 Jun; 62(23):e202300663. PubMed ID: 37016515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of trans-cleavage activity of Cas12a with engineered crRNA enables amplified nucleic acid detection.
    Nguyen LT; Smith BM; Jain PK
    Nat Commun; 2020 Sep; 11(1):4906. PubMed ID: 32999292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triplet repeat expansion generated by DNA slippage is suppressed by human flap endonuclease 1.
    Ruggiero BL; Topal MD
    J Biol Chem; 2004 May; 279(22):23088-97. PubMed ID: 15037629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applying biosensor development concepts to improve preamplification-free CRISPR/Cas12a-Dx.
    Hsieh K; Zhao G; Wang TH
    Analyst; 2020 Jul; 145(14):4880-4888. PubMed ID: 32478351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligase detection reaction amplification-activated CRISPR-Cas12a for single-molecule counting of FEN1 in breast cancer tissues.
    Wang ZY; Teng SQ; Zhao NN; Han Y; Li DL; Zhang CY
    Chem Commun (Camb); 2024 Mar; 60(22):3075-3078. PubMed ID: 38404229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.